| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.036 | 0.2 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.2 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.2 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |